KVUE vs PEP
KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories. PEP: Global diversified food and beverage company producing and distributing iconic snack and drink brands through a integrated direct-store delivery and wholesale network.
Side-by-side fundamentals
| Metric | KVUE | PEP | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $19.18 | $137.86 | |
| Market cap as of 2026-07-10 | $36.8B | $189.0B | |
| P/E as of 2026-07-10 | 22.70 | 21.64 | PEP lower |
| PEG as of 2026-07-10 | 2.72 | 3.73 | KVUE lower |
| Net margin as of 2026-07-10 | +10.6% | +9.2% | KVUE higher |
| Gross margin as of 2026-07-10 | +58.9% | +54.4% | KVUE higher |
| Operating margin as of 2026-07-10 | +17.1% | +12.4% | KVUE higher |
| ROE as of 2026-07-10 | +15.2% | +43.9% | PEP higher |
| ROA as of 2026-07-10 | +6.0% | +8.1% | PEP higher |
| Debt / equity as of 2026-07-10 | 0.82 | 2.47 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-10 | -0.1% | +4.3% | PEP higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | +2.8% | PEP higher |
| Dividend yield as of 2026-07-10 | +4.3% | +4.2% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 3 | 5 | PEP higher |
| Beta as of 2026-07-10 | 0.45 | 0.37 | |
| 1-year return as of 2026-07-09 close | -6.8% | +2.5% | PEP higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.